Repare Therapeutics Inc. (RPTX) Statistics & Valuation Metrics - Stocknear

Repare Therapeutics Inc.

NASDAQ: RPTX · Real-Time Price · USD
1.69
0.00 (0.00%)
At close: Sep 05, 2025, 3:59 PM
1.72
1.78%
After-hours: Sep 05, 2025, 06:52 PM EDT

Repare Therapeutics Statistics

Share Statistics

Repare Therapeutics has 42.96M shares outstanding. The number of shares has increased by 1.05% in one year.

42.96M
1.05%
0.9%
60.44%
30.82M
20
0.01%

Short Selling Information

The latest short interest is 634.15K, so 1.48% of the outstanding shares have been sold short.

634.15K
1.48%
2.17%
7.61

Valuation Ratios

The PE ratio is -0.66 and the forward PE ratio is -1.88. Repare Therapeutics's PEG ratio is 0.06.

-0.66
-1.88
1.04
7.3
0.37
-0.73
0.06
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Repare Therapeutics.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 6.77, with a Debt / Equity ratio of 0.01.

6.77
6.77
0.01
-0.02
-0.03
0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
$414.55K
$-656.5K
129
0.3
n/a

Taxes

1.44M
-1.73%

Stock Price Statistics

The stock price has increased by -40.07% in the last 52 weeks. The beta is 0.93, so Repare Therapeutics's price volatility has been higher than the market average.

0.93
-40.07%
1.54
1.51
66.52
290,011

Income Statement

In the last 12 months, Repare Therapeutics had revenue of 53.48M and earned -84.69M in profits. Earnings per share was -2.

53.48M
40.1M
-93.52M
-84.69M
-90.22M
-92.14M
-2
Full Income Statement

Balance Sheet

The company has 84.72M in cash and 1.93M in debt, giving a net cash position of 82.78M.

84.72M
1.93M
82.78M
-417.8M
130.49M
106.49M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -76.44M and capital expenditures 0, giving a free cash flow of -76.44M.

-76.44M
n/a
-76.44M
-1.8
Full Cash Flow Statement

Margins

Gross margin is 74.98%, with operating and profit margins of -174.88% and -158.37%.

74.98%
-174.88%
-155.67%
-158.37%
-168.71%
-174.88%
-142.95%

Dividends & Yields

RPTX does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for RPTX is $4.5, which is 166.3% higher than the current price. The consensus rating is "Buy".

$4.5
166.3%
Buy
3
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Scores

-4.51
2